NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Forecast, Predictions & Price Target

Analyst price target for CANF

Based on 1 analyst offering 12 month price targets for Can Fite Biopharma Ltd

Min Forecast
$10.00+880.39%
Avg Forecast
$10.00+880.39%
Max Forecast
$10.00+880.39%

Should I buy or sell CANF stock?

Based on 1 analyst offering ratings for Can Fite Biopharma Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CANF stock forecasts and price targets.

CANF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-15

1 of 1

CANF vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CANF$1.02$10.00+880.39%Strong Buy
DWTX$4.80$10.00+108.33%Buy
QNRX$8.80N/AN/A
BCLI$1.16N/AN/A
JBIO$11.14$15.50+39.14%Strong Buy

Can Fite Biopharma Stock Forecast FAQ

Is Can Fite Biopharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: CANF) stock is to Strong Buy CANF stock.

Out of 1 analyst, 1 (100%) are recommending CANF as a Strong Buy, 0 (0%) are recommending CANF as a Buy, 0 (0%) are recommending CANF as a Hold, 0 (0%) are recommending CANF as a Sell, and 0 (0%) are recommending CANF as a Strong Sell.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

What is CANF's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CANF price target, the average CANF price target is $10.00, with the highest CANF stock price forecast at $10.00 and the lowest CANF stock price forecast at $10.00.

The Wall Street analyst predicted that Can Fite Biopharma's share price could reach $10.00 by Apr 15, 2026. The average Can Fite Biopharma stock price prediction forecasts a potential upside of 880.39% from the current CANF share price of $1.02.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.